Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors

A. Orazi, S. Neiman r., Thomas Ulbright, N. A. Heerema, K. John, C. R. Nichols

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Background. Patients withmediastinal germcell tumors (MGCT) have a high incidence of hematologic malignancies unrelated to cytotoxic chemotherapy. It has been suggested that these leukemic conditions originate from a MGCT progenitor cell capable of undergoing nongerm cell (hematopoietic) differentiation. Methods. To assess this hypotheis, histologic material from six patients with MGCTs associated with leukemia was examined using monoclonal and polyclonal antibodies capable of labeling cells of the different marrow cell lineages. Results. Morpologically identifiable hematologic cells were found within the yolk sac tumor component of the MGCT in four of these patients. In three of the four cases, the cells consisted of poorly differentiated blast cells, whereas in the fourth, clusters of erythroblasts were identified. The leukemic cellls within the MGCT and in the bone marrow had similar morphology, constnat expression of the early progenitor cell marker CD34, and variable expression of more mature myeloid, monocytic, erythroid, and megakaryocytic markers.Three cases expressed p53, a nuclear protein associated with neoplastic transformation in a wide range of malignancies, including testicular cancers, but which rarely is reported in leukemias. Karyotype of the leukemia was assessed in five cases: two showed an i(12p), a cytogenetic marker of GCT not identified in the usual cases of leukemia. Conclusions. The results support the hypothesis that these leukemic conditions originate in the MGCT through a mechanism of differentiation from a yolk sac tumor-derived progenitor cell, with subsequent homing to the marrow.

Original languageEnglish
Pages (from-to)3873-3881
Number of pages9
JournalCancer
Volume71
Issue number12
StatePublished - 1993

Fingerprint

Endodermal Sinus Tumor
Germ Cell and Embryonal Neoplasms
Hematologic Neoplasms
Leukemia
Stem Cells
Bone Marrow
Erythroblasts
Testicular Neoplasms
Cell Lineage
Nuclear Proteins
Karyotype
Cytogenetics
Cell Differentiation
Neoplasms
Monoclonal Antibodies
Drug Therapy
Incidence

Keywords

  • hematologic differentiation
  • hematologic malignancies
  • mediatinal germ cell tumor
  • nongerm cell differentiation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. / Orazi, A.; Neiman r., S.; Ulbright, Thomas; Heerema, N. A.; John, K.; Nichols, C. R.

In: Cancer, Vol. 71, No. 12, 1993, p. 3873-3881.

Research output: Contribution to journalArticle

@article{6c587d0a61c44fef9505904e105c1efd,
title = "Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors",
abstract = "Background. Patients withmediastinal germcell tumors (MGCT) have a high incidence of hematologic malignancies unrelated to cytotoxic chemotherapy. It has been suggested that these leukemic conditions originate from a MGCT progenitor cell capable of undergoing nongerm cell (hematopoietic) differentiation. Methods. To assess this hypotheis, histologic material from six patients with MGCTs associated with leukemia was examined using monoclonal and polyclonal antibodies capable of labeling cells of the different marrow cell lineages. Results. Morpologically identifiable hematologic cells were found within the yolk sac tumor component of the MGCT in four of these patients. In three of the four cases, the cells consisted of poorly differentiated blast cells, whereas in the fourth, clusters of erythroblasts were identified. The leukemic cellls within the MGCT and in the bone marrow had similar morphology, constnat expression of the early progenitor cell marker CD34, and variable expression of more mature myeloid, monocytic, erythroid, and megakaryocytic markers.Three cases expressed p53, a nuclear protein associated with neoplastic transformation in a wide range of malignancies, including testicular cancers, but which rarely is reported in leukemias. Karyotype of the leukemia was assessed in five cases: two showed an i(12p), a cytogenetic marker of GCT not identified in the usual cases of leukemia. Conclusions. The results support the hypothesis that these leukemic conditions originate in the MGCT through a mechanism of differentiation from a yolk sac tumor-derived progenitor cell, with subsequent homing to the marrow.",
keywords = "hematologic differentiation, hematologic malignancies, mediatinal germ cell tumor, nongerm cell differentiation",
author = "A. Orazi and {Neiman r.}, S. and Thomas Ulbright and Heerema, {N. A.} and K. John and Nichols, {C. R.}",
year = "1993",
language = "English",
volume = "71",
pages = "3873--3881",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors

AU - Orazi, A.

AU - Neiman r., S.

AU - Ulbright, Thomas

AU - Heerema, N. A.

AU - John, K.

AU - Nichols, C. R.

PY - 1993

Y1 - 1993

N2 - Background. Patients withmediastinal germcell tumors (MGCT) have a high incidence of hematologic malignancies unrelated to cytotoxic chemotherapy. It has been suggested that these leukemic conditions originate from a MGCT progenitor cell capable of undergoing nongerm cell (hematopoietic) differentiation. Methods. To assess this hypotheis, histologic material from six patients with MGCTs associated with leukemia was examined using monoclonal and polyclonal antibodies capable of labeling cells of the different marrow cell lineages. Results. Morpologically identifiable hematologic cells were found within the yolk sac tumor component of the MGCT in four of these patients. In three of the four cases, the cells consisted of poorly differentiated blast cells, whereas in the fourth, clusters of erythroblasts were identified. The leukemic cellls within the MGCT and in the bone marrow had similar morphology, constnat expression of the early progenitor cell marker CD34, and variable expression of more mature myeloid, monocytic, erythroid, and megakaryocytic markers.Three cases expressed p53, a nuclear protein associated with neoplastic transformation in a wide range of malignancies, including testicular cancers, but which rarely is reported in leukemias. Karyotype of the leukemia was assessed in five cases: two showed an i(12p), a cytogenetic marker of GCT not identified in the usual cases of leukemia. Conclusions. The results support the hypothesis that these leukemic conditions originate in the MGCT through a mechanism of differentiation from a yolk sac tumor-derived progenitor cell, with subsequent homing to the marrow.

AB - Background. Patients withmediastinal germcell tumors (MGCT) have a high incidence of hematologic malignancies unrelated to cytotoxic chemotherapy. It has been suggested that these leukemic conditions originate from a MGCT progenitor cell capable of undergoing nongerm cell (hematopoietic) differentiation. Methods. To assess this hypotheis, histologic material from six patients with MGCTs associated with leukemia was examined using monoclonal and polyclonal antibodies capable of labeling cells of the different marrow cell lineages. Results. Morpologically identifiable hematologic cells were found within the yolk sac tumor component of the MGCT in four of these patients. In three of the four cases, the cells consisted of poorly differentiated blast cells, whereas in the fourth, clusters of erythroblasts were identified. The leukemic cellls within the MGCT and in the bone marrow had similar morphology, constnat expression of the early progenitor cell marker CD34, and variable expression of more mature myeloid, monocytic, erythroid, and megakaryocytic markers.Three cases expressed p53, a nuclear protein associated with neoplastic transformation in a wide range of malignancies, including testicular cancers, but which rarely is reported in leukemias. Karyotype of the leukemia was assessed in five cases: two showed an i(12p), a cytogenetic marker of GCT not identified in the usual cases of leukemia. Conclusions. The results support the hypothesis that these leukemic conditions originate in the MGCT through a mechanism of differentiation from a yolk sac tumor-derived progenitor cell, with subsequent homing to the marrow.

KW - hematologic differentiation

KW - hematologic malignancies

KW - mediatinal germ cell tumor

KW - nongerm cell differentiation

UR - http://www.scopus.com/inward/record.url?scp=0027180999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027180999&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 3873

EP - 3881

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -